GL1X · GenesisL1 explorer

UniProt A0A840P3H4

Cysteine dioxygenase (A0A840P3H4)

Cysteine dioxygenase (UniProt A0A840P3H4): 7 experimental structures on GenesisL1, 8 ligands bound, 22 pockets. Binding sites, pockets, druggability and 3D structures in GL1X.

UniProt
A0A840P3H4
Protein
Cysteine dioxygenase
Experimental structures
7
Predicted models
0
Ligands
8
Pockets
22 · 7 records with a druggable one

Structures

7 records of A0A840P3H4 in the MolNFT archive: 7 experimental, 0 predicted.

EntryTitleMethodChainsLigandsPockets
8QFLErgothioneine dioxygenase from Thermocatellispora tengchongensis in complex with ironx-ray diffractionA, BFE, MG3 (best 0.66)
8QFMErgothioneine dioxygenase from Thermocatellispora tengchongensis in complex with manganesex-ray diffractionA, BPEO, MN, MG3 (best 0.66)
8QFNErgothioneine dioxygenase from Thermocatellispora tengchongensis in complex with manganese and in…x-ray diffractionA, BMG, MN3 (best 0.66)
8QFOErgothioneine dioxygenase, variant Y149F, from Thermocatellispora tengchongensis in complex with…x-ray diffractionA, BMN, MG3 (best 0.71)
8QFPErgothioneine dioxygenase from Thermocatellispora tengchongensis in complex with manganese and in…x-ray diffractionA, BMN, CL, MG3 (best 0.67)
8QFQErgothioneine dioxygenase, variant H147A, from Thermocatellispora tengchongensis in complex with…x-ray diffractionA, BMN, MG4 (best 0.60)
8QFRErgothioneine dioxygenase from Thermocatellispora tengchongensis in complex with nickel and…x-ray diffractionA, BLW8, MG, NI, CA3 (best 0.68)

Ligands

  • MG · Magnesium ion · in 7 records
  • MN · Manganese (II) ion · in 5 records
  • CA · Calcium ion · in 1 record
  • CL · Chloride ion · in 1 record
  • FE · Fe (III) ion · in 1 record
  • LW8 · trimethyl-[(2S)-1-oxidanyl-1-oxidanylidene-3-(2-sulfanylidene-1,3-dihydroimidazol-4-yl)propan-2-yl]azanium · in 1 record
  • NI · Nickel (II) ion · in 1 record
  • PEO · Hydrogen peroxide · in 1 record

Elsewhere

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.